IP Library Patent Application 13281802
Patent Application
App. No. 13/281,802

COATINGS AND METHODS FOR CONTROLLED ELUTION OF HYDROPHILIC ACTIVE AGENTS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/281,802
Abstract

Embodiments of the invention include multi-layer coatings and methods for controlling the elution of hydrophilic active agents. In an embodiment, the invention includes a medical device including a substrate, a primer polymer layer disposed on the substrate, an expandable layer disposed on the primer polymer layer, and a hydrophilic active agent dispersed within the expandable layer. In an embodiment, the invention includes a method of forming a medical device including depositing a primer layer onto a substrate, the primer layer comprising a primer polymer. The method can further include depositing an expandable layer onto the primer layer, the expandable layer including an expandable polymer, and a hydrophilic active agent. The expandable layer can be deposited with a solvent that is effective to solvate both the expandable polymer and the primer polymer. Other embodiments are also included herein.

Claims (29)

1 . A medical device comprising:

a substrate;

a primer polymer layer disposed on the substrate;

an expandable layer disposed on the primer polymer layer; and

a hydrophilic active agent dispersed within the expandable layer.

2 . The medical device of claim 1 , further comprising a top coat disposed on the expandable layer, the top coat comprising polyethylene-co-vinyl acetate (PEVA).

3 . The medical device of claim 2 , the polyethylene-co-vinyl acetate having a vinyl acetate concentration of between about 12 percent and 33 percent by weight.

4 . The medical device of claim 1 , the expandable layer configured to expand in volume at least about 5% after insertion into a subject.

5 . The medical device of claim 2 , the expandable layer comprising polyethylene-co-vinyl acetate (PEVA).

6 . The medical device of claim 5 , the polyethylene-co-vinyl acetate in the expandable layer having a vinyl acetate concentration of greater than or equal to about 33 percent by weight and less than or equal to about 40 percent by weight.

7 . The medical device of claim 1 , the expandable layer comprising at least one selected from the group consisting of cross-linked polysiloxane (silicone rubber) and butyl rubber.

8 . The medical device of claim 1 , the expandable layer comprising a hydrogel.

9 . The medical device of claim 1 , the expandable layer comprising poly lactide-co-glycolide (PLGA).

10 . The medical device of claim 1 , the expandable layer having a thickness of at least about 5 microns.

11 . The medical device of claim 1 , the primer layer configured to expand in volume less than about 5% after insertion into a subject.

12 . The medical device of claim 1 , the primer polymer layer comprising poly-n-butyl methacrylate (PBMA).

13 . The medical device of claim 1 , the primer polymer layer comprising polystyrene.

14 . The medical device of claim 1 , the primer polymer layer having a thickness of at least about 1 micron.

15 . The medical device of claim 1 , the hydrophilic active agent comprising at least one selected from the group consisting of a protein and a nucleic acid.

16 . The medical device of claim 1 , the expandable layer comprising at least trace amounts of a solvent effective to solvate the primer polymer layer disposed on the substrate.

17 . The medical device of claim 1 , the substrate comprising a portion of at least one selected from the group consisting of an eye coil, a stent, an electrical stimulation lead, and a bone screw.

18 . The medical device of claim 1 , the substrate selected from the group consisting of glasses, metals, and ceramics.

19 . A method of forming a medical device comprising:

depositing a primer layer onto a substrate, the primer layer comprising a primer polymer; and

depositing an expandable layer onto the primer layer, the expandable layer comprising

a expandable polymer, and

a hydrophilic active agent;

wherein the expandable layer is deposited with a solvent that is effective to solvate both the expandable polymer and the primer polymer.

20 . The method of claim 19 , further comprising depositing a top coat onto the expandable layer.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2025
From: SURMODICS, INC.
To: SURMODICS COATINGS, LLC
Reel/Frame 073928/0178 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2011
From: CHAPPA, RALPH A.; BURKSTRAND, MICHAEL J.; BABCOCK, DAVID E.
To: SURMODICS, INC.
Reel/Frame 027435/0281 →